Location: New York, NY
CIK: 0002011932 · Show all filings
Period: Q4 2023 (Next →)
Filing Date: Feb 15, 2024
Total Value: $101M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| RDY | DR REDDYS LABS LTD | 90,000 | $6.262M | 6.2% | $69.58 | — | ADR | 256135203 |
| LLY | ELI LILLY & CO | 9,700 | $5.654M | 5.6% | $575.10 | 0.0% | COM | 532457108 |
| — | IMMUNOGEN INC | 186,900 | $5.542M | 5.5% | $29.65 | — | COM | 45253H101 |
| CI | THE CIGNA GROUP | 15,300 | $4.582M | 4.5% | $280.77 | 0.0% | COM | 125523100 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 111,300 | $4.414M | 4.4% | $29.41 | 0.0% | COM NEW | 15117B202 |
| TGTX | TG THERAPEUTICS INC | 203,300 | $3.472M | 3.4% | $11.62 | 0.0% | COM | 88322Q108 |
| RYTM | RHYTHM PHARMACEUTICALS INC | 72,203 | $3.319M | 3.3% | $31.55 | 0.0% | COM | 76243J105 |
| — | ALPINE IMMUNE SCIENCES INC | 173,500 | $3.307M | 3.3% | $19.06 | — | COM | 02083G100 |
| DXCM | DEXCOM INC | 24,828 | $3.081M | 3.0% | $102.16 | 0.0% | COM | 252131107 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 13,202 | $3.055M | 3.0% | $174.99 | 0.0% | COM | 558868105 |
| CYTK | CYTOKINETICS INC | 34,908 | $2.914M | 2.9% | $36.21 | 0.0% | COM NEW | 23282W605 |
| — | INHIBRX INC | 73,158 | $2.78M | 2.7% | $38.00 | — | COM | 45720L107 |
| GPCR | STRUCTURE THERAPEUTICS INC | 68,100 | $2.776M | 2.7% | $40.76 | — | SPONSORED ADS | 86366E106 |
| RCKT | ROCKET PHARMACEUTICALS INC | 91,800 | $2.751M | 2.7% | $22.07 | 0.0% | COM | 77313F106 |
| BBIO | BRIDGEBIO PHARMA INC | 65,113 | $2.629M | 2.6% | $30.03 | 0.0% | COM | 10806X102 |
| ONC | BEIGENE LTD | 12,800 | $2.309M | 2.3% | $180.36 | — | SPONSORED ADR | 07725L102 |
| LEGN | LEGEND BIOTECH CORP | 37,900 | $2.28M | 2.3% | $60.17 | — | SPONSORED ADS | 52490G102 |
| PEN | PENUMBRA INC | 8,553 | $2.151M | 2.1% | $221.05 | 0.0% | COM | 70975L107 |
| ISRG | INTUITIVE SURGICAL INC | 6,358 | $2.145M | 2.1% | $298.09 | 0.0% | COM NEW | 46120E602 |
| BIIB | BIOGEN INC | 8,200 | $2.122M | 2.1% | $245.62 | 0.0% | COM | 09062X103 |
| — | INTRA-CELLULAR THERAPIES INC | 28,300 | $2.027M | 2.0% | $71.62 | — | COM | 46116X101 |
| BHVN | BIOHAVEN LTD | 45,467 | $1.946M | 1.9% | $31.10 | 0.0% | COM | G1110E107 |
| INSM | INSMED INC | 61,500 | $1.906M | 1.9% | $25.93 | 0.0% | COM PAR $.01 | 457669307 |
| LNTH | LANTHEUS HLDGS INC | 29,100 | $1.804M | 1.8% | $67.75 | 0.0% | COM | 516544103 |
| CPRX | CATALYST PHARMACEUTICALS INC | 105,500 | $1.773M | 1.8% | $13.67 | 0.0% | COM | 14888U101 |
| TARS | TARSUS PHARMACEUTICALS INC | 84,400 | $1.709M | 1.7% | $16.70 | 0.0% | COM | 87650L103 |
| STTK | SHATTUCK LABS INC | 223,300 | $1.592M | 1.6% | $2.73 | 0.0% | COM | 82024L103 |
| VRTX | VERTEX PHARMACEUTICALS INC | 3,900 | $1.587M | 1.6% | $369.42 | 0.0% | COM | 92532F100 |
| IMTX | IMMATICS N.V | 129,900 | $1.368M | 1.4% | $9.21 | 0.0% | SHS | N44445109 |
| PRTA | PROTHENA CORP PLC | 36,384 | $1.322M | 1.3% | $38.49 | 0.0% | SHS | G72800108 |
| GERN | GERON CORP | 607,500 | $1.282M | 1.3% | $1.94 | 0.0% | COM | 374163103 |
| TSHA | TAYSHA GENE THERAPIES INC | 693,300 | $1.227M | 1.2% | $1.99 | 0.0% | COM SHS | 877619106 |
| MGNX | MACROGENICS INC | 125,900 | $1.211M | 1.2% | $6.91 | 0.0% | COM | 556099109 |
| NTRA | NATERA INC | 18,650 | $1.168M | 1.2% | $49.96 | 0.0% | COM | 632307104 |
| — | IGM BIOSCIENCES INC | 135,596 | $1.127M | 1.1% | $8.31 | — | COM | 449585108 |
| CABA | CABALETTA BIO INC | 46,700 | $1.06M | 1.0% | $16.81 | 0.0% | COM | 12674W109 |
| — | MIRATI THERAPEUTICS INC | 15,896 | $934K | 0.9% | $58.75 | — | COM | 60468T105 |
| PLRX | PLIANT THERAPEUTICS INC | 49,580 | $898K | 0.9% | $15.21 | 0.0% | COM | 729139105 |
| — | SAGE THERAPEUTICS INC | 35,257 | $764K | 0.8% | $21.67 | — | COM | 78667J108 |
| — | SHOCKWAVE MED INC | 4,000 | $762K | 0.8% | $190.56 | — | COM | 82489T104 |
| TVTX | TRAVERE THERAPEUTICS INC | 83,987 | $755K | 0.7% | $7.28 | 0.0% | COM | 89422G107 |
| PACB | PACIFIC BIOSCIENCES CALIF IN | 75,300 | $739K | 0.7% | $8.18 | 0.0% | COM | 69404D108 |
| ESTA | ESTABLISHMENT LABS HLDGS INC | 27,600 | $715K | 0.7% | $29.28 | 0.0% | COM | G31249108 |
| — | SUTRO BIOPHARMA INC | 153,600 | $659K | 0.7% | $4.29 | — | COM | 869367102 |
| EYPT | EYEPOINT PHARMACEUTICALS INC | 26,400 | $610K | 0.6% | $11.18 | 0.0% | COM NEW | 30233G209 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 9,744 | $588K | 0.6% | $51.54 | 0.0% | CLASS A ORD | 61559X104 |
| PROCF | PROCAPS GROUP SA | 126,901 | $516K | 0.5% | $2.91 | 0.0% | SHS | L7756P102 |
| APLS | APELLIS PHARMACEUTICALS INC | 7,249 | $434K | 0.4% | $50.73 | 0.0% | COM | 03753U106 |
| — | GRACELL BIOTECHNOLOGIES INC | 40,974 | $411K | 0.4% | $10.04 | — | SPONSORED ADS | 38406L103 |
| VYNE | VYNE THERAPEUTICS INC | 118,100 | $275K | 0.3% | $3.12 | 0.0% | COM | 92941V308 |
| — | REGULUS THERAPEUTICS INC | 178,404 | $228K | 0.2% | $1.28 | — | COM | 75915K309 |
| — | KINNATE BIOPHARMA INC | 83,848 | $199K | 0.2% | $2.37 | — | COM | 49705R105 |